Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
NFC Market by Offering (NFC ICs, NFC Antennas, NFC Tags, NFC Readers), Operating Mode (Reader Emulation, Peer-to-Peer, Card Emulation), Use Cases (Payment and Transactions, Product Identification, Ticketing, Access Control) - Global Forecast to 2029
... global NFC market was valued at USD 21.69 billion in 2024 and is projected to reach USD 30.55 billion by 2029; it is expected to register a CAGR of 7.1% during the forecast period. NFC ... Read More
-
Erythropoietin Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global erythropoietin drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global erythropoietin ... Read More
-
Wireless Power Transmission Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 6.0% during 2025-2034. This report on global wireless power transmission market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Global Biotech Ingredients Market Size Study, by Type (Active Pharmaceutical Ingredients, Biosimilars), by Product (Monoclonal Antibodies, Vaccines, Hormones and Growth Factors, Cytokines, Fusion Proteins, Therapeutic Enzymes, Blood Factors), by Expression Systems (Mammalian, Microbial, Yeast, Plant, Insect), and Regional Forecasts 2022-2032
... Insect), and Regional Forecasts 2022-2032 Global Biotech Ingredients Market was valued at approximately USD 59.10 billion in 2023 and is expected to grow at a CAGR of 4.81% during the forecast period of 2024 to ... Read More
-
Global Rituximab Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Rituximab Biosimilars market. Rituximab Biosimilars ... Read More
-
Global Erythropoietin Stimulating Agents Market 2024-2028
... stimulating agents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Global Immunology Biosimilars Market (2024 Edition): Analysis By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel, By Region, By Country: Market Insights and Forecast (2020-2030)
... report titled “Global Immunology Biosimilars Market (2024 Edition)” which provides an analysis of the Global Immunology Biosimilars industry in terms of market segmentation By Indication (Arthritis, Irritable Bowel Disease, Other Indications), By Distribution Channel (Hospital ... Read More
-
Global Ranibizumab Drugs and Biosimilars Market Growth 2024-2030
... disease.Biosimilars of ranibizumab are biologic products that are highly similar to the original reference drug(ranibizumab)in terms of structure,efficacy,safety,and quality.These biosimilars aim to provide more affordable treatment options while maintaining therapeutic equivalence to the original biologic ... Read More
-
PEGylated Proteins
... at a CAGR of 9.1% over the analysis period 2023-2030. PEGylated Protein Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.3 Billion by the end ... Read More
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
... Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029. Major pharmaceutical companies have ... Read More
-
Global G-CSF and G-CSF Biosimilars Market Growth 2024-2030
... downstream market, the G-CSF and G-CSF Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
India Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F India generic drugs market is projected to witness a CAGR of 8.29% during the forecast period FY2025-FY2032, growing from USD ... Read More
-
Japan Biosimilars Market, By Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, Other), By Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2020-2030F
... By Region, Competition Forecast & Opportunities, 2020-2030F Japan Biosimilars Market was valued at USD 502.09 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.12% through ... Read More
-
Japan Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, FY2018-FY2032F Japan generic drugs market is projected to witness a CAGR of 7.81% during the forecast period FY2024-FY2032, growing from USD ... Read More
-
Global Biosimilars Treatment Market Growth (Status and Outlook) 2024-2030
... market, the Biosimilars Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilars Treatment ... Read More
-
United States Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F United States generic drugs market is projected to witness a CAGR of 6.68% during the forecast period 2024-2031, growing ... Read More
-
Vietnam Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Diabetology, Respiratory, Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Vietnam generic drugs market is projected to witness a CAGR of 8.39% during the forecast period 2024-2031, growing from USD ... Read More
-
Bioburden Testing
... growing at a CAGR of 9.8% over the period 2023-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record 10.2% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Erythropoietin Drugs
... growing at a CAGR of 3.7% over the period 2023-2030. Epoetin-Alfa Drugs, one of the segments analyzed in the report, is expected to record 3.9% CAGR and reach US$8.3 Billion by the end of the ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
... vital insights that can help shape strategy for business development, product development and investments. Key Features: Business trends analysis In-depth industry overview Technology trends analysis Forecasts Spending, investment, and consumption discussions In-depth industry statistics and ... Read More
-
Global Biosimilars Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Global gastroenterology market growth is ... Read More
-
Japan Human Insulin Market By Product Type (Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin, Biosimilars), By Application (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus), By Type (Human Insulin, Insulin Analog), By Distribution Channel (Hospitals, Retail Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
... Pharmacies, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F Japan Human Insulin Market was valued at USD 840.23 Million in 2024 and is expected to reach USD 1206.28 Million by 2030 with a CAGR ... Read More
-
Regulatory Affairs Outsourcing Market Report by Services (Regulatory Consulting, Legal Representation, Regulatory Writing and Publishing, Product Registration and Clinical Trial Applications, and Others), Company Size (Small, Medium, Large), Category (Generic Drugs, Innovator Drugs, Biologic Drugs, Biosimilars, Medical Devices, and Others), Indication (Oncology, Neurology, Cardiology, Immunology, and Others), Stage (Preclinical, Clinical, PMA (Post Market Authorization)), End User (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies), and Region 2024-2032
... Biosimilars, Medical Devices, and Others), Indication (Oncology, Neurology, Cardiology, Immunology, and Others), Stage (Preclinical, Clinical, PMA (Post Market Authorization)), End User (Medical Device Companies, Pharmaceutical Companies, Biotechnology Companies), and Region 2024-2032 The global regulatory affairs ... Read More
-
Erythropoietin Drugs Market Report by Drug Class (Biologics, Biosimilars), Product Type (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, and Others), Application (Hematology, Kidney Disorder, Cancer, and Others), End-User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2024-2032
... erythropoietin drugs market size reached US$ 11.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The growing ... Read More
Research Assistance
